Originova Medical is developing an innovative injectable hydrogel that is designed to address the long-term damage caused by myocardial infarction (MI), commonly known as a heart attack. This hydrogel, when injected into the heart tissue, helps in reducing scarring and enhances tissue regeneration, ...See more
Headquarters:
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2024 (2 years)
Address:
null
LOW
spending power
